GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Increased by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.1% during the second quarter, HoldingsChannel reports. The institutional investor owned 38,905 shares of the company’s stock after buying an additional 1,525 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in GE HealthCare Technologies were worth $3,031,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Capital Research Global Investors grew its position in shares of GE HealthCare Technologies by 5.2% during the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after buying an additional 2,647,204 shares during the last quarter. Vanguard Group Inc. raised its position in shares of GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after purchasing an additional 4,107,746 shares during the period. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 9.4% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock worth $426,186,000 after purchasing an additional 471,910 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in GE HealthCare Technologies by 41.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,875,589 shares of the company’s stock worth $145,021,000 after buying an additional 550,612 shares during the last quarter. Finally, Perpetual Ltd acquired a new stake in GE HealthCare Technologies in the first quarter worth $96,135,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 2.4 %

Shares of GE HealthCare Technologies stock opened at $90.62 on Friday. The business has a fifty day simple moving average of $83.64 and a 200-day simple moving average of $83.31. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The firm has a market cap of $41.36 billion, a price-to-earnings ratio of 26.50, a price-to-earnings-growth ratio of 3.26 and a beta of 1.17. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. GE HealthCare Technologies’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the company earned $0.92 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s payout ratio is 3.51%.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at approximately $1,414,377.02. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on GEHC. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research report on Wednesday. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target on the stock. Stifel Nicolaus started coverage on GE HealthCare Technologies in a research report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price objective for the company. Finally, JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. Six analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $95.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.